Pan X - Search Results

1

Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol.

Pan X, Liang L, Si R, Wang J, Zhang Q, Zhou H, Zhang L, Zhang J. Pan X, et al. Eur J Med Chem. 2019 Feb 1;163:1-9. doi: 10.1016/j.ejmech.2018.11.042. Epub 2018 Nov 22. Eur J Med Chem. 2019. PMID: 30503935

2

Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents.

Zhang J, Zhang Y, Pan X, Wang S, He L. Zhang J, et al. Among authors: pan x. Med Chem. 2011 Jul;7(4):286-94. doi: 10.2174/157340611796150914. Med Chem. 2011. PMID: 21568882

3

Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-aminosalicylic acid derivatives as neuraminidase inhibitors.

Zhang J, Shan Y, Pan X, Wang C, Xu W, He L. Zhang J, et al. Among authors: pan x. Chem Biol Drug Des. 2011 Oct;78(4):709-17. doi: 10.1111/j.1747-0285.2011.01179.x. Epub 2011 Sep 6. Chem Biol Drug Des. 2011. PMID: 21752201

4

Development of 5-Fluorouracil derivatives as anticancer agents.

Pan X, Wang C, Wang F, Li P, Hu Z, Shan Y, Zhang J. Pan X, et al. Curr Med Chem. 2011;18(29):4538-56. doi: 10.2174/092986711797287584. Curr Med Chem. 2011. PMID: 21864282 Review.

5

Facile synthesis and biological evaluation of novel symmetrical biphenyls as antitumor agents.

Zhang J, Zhang Y, Pan X, Wang C, Hu Z, Wang S, He L. Zhang J, et al. Among authors: pan x. Med Chem. 2012 Mar;8(2):145-50. doi: 10.2174/157340612800493656. Med Chem. 2012. PMID: 22385184

6

A novel and facile synthetic approach for tasigna.

Pan X, Lu W, Li P, Wang F, Wang C, Hu Z, Zhang J. Pan X, et al. Med Chem. 2012 Sep;8(5):985-9. doi: 10.2174/157340612802084207. Med Chem. 2012. PMID: 22741607

7

Structural modeling and identification of imperatorin as novel L-type calcium channel blocker.

Lu W, Zhang T, Li P, Wang F, Pan X, Wang C, Hu Z, Zhang J. Lu W, et al. Among authors: pan x. Med Chem. 2013 Nov;9(7):993-8. doi: 10.2174/1573406411309070013. Med Chem. 2013. PMID: 23061602

8

Design, synthesis and biological activities of Nilotinib derivates as antitumor agents.

Pan X, Wang F, Zhang Y, Gao H, Hu Z, Wang S, Zhang J. Pan X, et al. Bioorg Med Chem. 2013 May 1;21(9):2527-34. doi: 10.1016/j.bmc.2013.02.036. Epub 2013 Mar 5. Bioorg Med Chem. 2013. PMID: 23538233

9

Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors.

Pan X, Dong J, Gao H, Wang F, Zhang Y, Wang S, Zhang J. Pan X, et al. Chem Biol Drug Des. 2014 May;83(5):592-9. doi: 10.1111/cbdd.12272. Epub 2014 Mar 14. Chem Biol Drug Des. 2014. PMID: 24330598

10

Discovery of novel Bcr-Abl inhibitors targeting myristoyl pocket and ATP site.

Dong J, Lu W, Pan X, Su P, Shi Y, Wang J, Zhang J. Dong J, et al. Among authors: pan x. Bioorg Med Chem. 2014 Dec 15;22(24):6876-84. doi: 10.1016/j.bmc.2014.10.030. Epub 2014 Oct 27. Bioorg Med Chem. 2014. PMID: 25464886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,988 results

Search Page

Filters